Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IncobotulinumtoxinA for complex regional pain syndrome
RBR-9h7h2d5Recruiting
- Sponsor
- Departamento de Medicina Clínica da Universidade Federal do Ceará
- Start
- Aug 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of botulinum toxin type A in complex regional pain syndrome (CRPS) (2 arms), sponsored by Departamento de Medicina Clínica da Universidade Federal do Ceará. Started Aug 2025; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on RBR-9h7h2d5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9h7h2d5.